Regencell Bioscience Holdings Stock Price, News & Analysis
RGC
NASDAQ
Company Description
Welcome to the overview page for Regencell Bioscience Holdings (RGC), where you can find comprehensive stock information and company updates.
Explore the latest news on strategic partnerships, quarterly and annual financial results, and regulatory filings including SEC reports and insider transactions.
Visualize performance trends using the interactive price chart, and keep track of upcoming events such as earnings calls, dividend dates, and investor conferences.
Stock Performance
$60.00
-2.04%
1.25
Last updated: May 3, 2025 at 15:59
-52.95 %
Performance 1 year
$377.5M
Market Cap
13.0M
Shares outstanding
Latest News
SEC Filings
No SEC filings available for Regencell Bioscience Holdings.
Financial Highlights
$3,163,000,000
Revenue (TTM)
$112,300,000
Net Income (TTM)
$0.72
Diluted EPS (TTM)
$409,900,000
Operating Cash Flow
3.55%
Net Profit Margin
8.59%
Oper. Profit Margin
Upcoming Events
Frequently Asked Questions
What is the current stock price of Regencell Bioscience Holdings (RGC)?
The current stock price of Regencell Bioscience Holdings (RGC) is $61.25 as of May 2, 2025.
What is the market cap of Regencell Bioscience Holdings (RGC)?
The market cap of Regencell Bioscience Holdings (RGC) is approximately 377.5M.
What is the revenue (TTM) of Regencell Bioscience Holdings (RGC) stock?
The trailing twelve months (TTM) revenue of Regencell Bioscience Holdings (RGC) is $3,163,000,000.
What is the net income of Regencell Bioscience Holdings (RGC)?
The trailing twelve months (TTM) net income of Regencell Bioscience Holdings (RGC) is $112,300,000.
What is the earnings per share (EPS) of Regencell Bioscience Holdings (RGC)?
The diluted earnings per share (EPS) of Regencell Bioscience Holdings (RGC) is $0.72 on a trailing twelve months (TTM) basis.
What is the operating cash flow of Regencell Bioscience Holdings (RGC)?
The operating cash flow of Regencell Bioscience Holdings (RGC) is $409,900,000.
What is the profit margin of Regencell Bioscience Holdings (RGC)?
The net profit margin of Regencell Bioscience Holdings (RGC) is 3.55%.
What is the operating margin of Regencell Bioscience Holdings (RGC)?
The operating profit margin of Regencell Bioscience Holdings (RGC) is 8.59%.
What is the current ratio of Regencell Bioscience Holdings (RGC)?
The current ratio of Regencell Bioscience Holdings (RGC) is 0.83, indicating the company's ability to pay short-term obligations.
What is the operating income of Regencell Bioscience Holdings (RGC)?
The operating income of Regencell Bioscience Holdings (RGC) is $271,700,000.